guardant

Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening

Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening

Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening

Karren Franco 29 July، 2024

Shield is first blood test approved by FDA as a primary screening option for colorectal cancer and...

Hikma and Guardant Health sign exclusive partnership agreement to bring transformative cancer diagnostic technology

Hikma and Guardant Health sign exclusive partnership agreement to bring transformative cancer diagnostic technology

Hikma and Guardant Health sign exclusive partnership agreement to bring transformative cancer diagnostic technology

Karren Franco 8 January، 2024

to the Middle East and North Africa Amman, Jordan Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today...